Paul F. Truex

2014

In 2014, Paul F. Truex earned a total compensation of $1.4M as Former CEO and Director at Anthera Pharmaceuticals, a 56% decrease compared to previous year.

Compensation breakdown

Non-Equity Incentive Plan$401,718
Option Awards$449,759
Salary$515,000
Stock Awards$12,750
Total$1,379,227

Truex received $515K in salary, accounting for 37% of the total pay in 2014.

Truex also received $401.7K in non-equity incentive plan, $449.8K in option awards and $12.8K in stock awards.

Rankings

In 2014, Paul F. Truex's compensation ranked 6,158th out of 13,032 executives tracked by ExecPay. In other words, Truex earned more than 52.7% of executives.

ClassificationRankingPercentile
All
6,158
out of 13,032
53rd
Division
Manufacturing
2,238
out of 4,965
55th
Major group
Chemicals And Allied Products
746
out of 1,690
56th
Industry group
Drugs
583
out of 1,369
57th
Industry
Pharmaceutical Preparations
446
out of 1,042
57th
Source: SEC filing on March 16, 2017.

Truex's colleagues

We found six more compensation records of executives who worked with Paul F. Truex at Anthera Pharmaceuticals in 2014.

2014

Colin Hislop

Anthera Pharmaceuticals

Chief Medical Officer

2014

Debra Odink

Anthera Pharmaceuticals

Chief Technology Officer

2014

May Liu

Anthera Pharmaceuticals

SVP, Finance & Administration

2014

Chuck Olson

Anthera Pharmaceuticals

Chief Technology Officer

2014

Klara Dickinson

Anthera Pharmaceuticals

Senior Vice President Chief Regulatory Officer

2014

Klara Dickinson-Eason

Anthera Pharmaceuticals

SVP, Chief Regulatory Office

You may also like